Home › Colorectal Cancer › Connecticut › Stamford
Colorectal Cancer clinical trials in Stamford, CT
3 studies for Colorectal Cancer are looking for participants at sites in and around Stamford (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
RecruitingPhase 2
- Northwell Health Cancer Institute at Huntington, Greenlawn · 16 mi away
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Stamford Hospital, Stamford
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
RecruitingPhase 1
- Northwell Health Cancer Institute at Huntington, Greenlawn · 16 mi away
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX101 studies
- New York City, NY86 studies
- Nashville, TN67 studies
- Boston, MA62 studies
- Los Angeles, CA61 studies
- Arlington, VA54 studies
- St. Louis, MO51 studies
- San Antonio, TX43 studies
- Philadelphia, PA41 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Tampa, FL36 studies
Other studies in Stamford
- Lung Cancer10 studies
- Breast Cancer9 studies
- Non-Small Cell Lung Cancer9 studies
- Migraine8 studies
- Ovarian Cancer5 studies
- Prostate Cancer5 studies
- Cardiovascular Disease4 studies
- Obesity4 studies
- Pancreatic Cancer4 studies
- Metastatic Cancer4 studies
- Heart Failure3 studies
- Neurologic Diseases3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.